DE NITTO, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 768
EU - Europa 556
AS - Asia 333
AF - Africa 20
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.683
Nazione #
US - Stati Uniti d'America 764
SG - Singapore 164
CN - Cina 135
RU - Federazione Russa 112
IT - Italia 96
IE - Irlanda 87
FR - Francia 77
SE - Svezia 66
DE - Germania 55
FI - Finlandia 27
TG - Togo 19
GB - Regno Unito 17
KR - Corea 11
BE - Belgio 5
HK - Hong Kong 5
VN - Vietnam 5
AU - Australia 4
CA - Canada 3
ID - Indonesia 3
IR - Iran 3
AT - Austria 2
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
PL - Polonia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IS - Islanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.683
Città #
Chandler 260
Singapore 134
Ashburn 105
Dublin 84
Beijing 42
Redmond 37
Lawrence 25
Princeton 25
Verona 22
Helsinki 21
Sindelfingen 20
Lomé 19
Seattle 19
Wilmington 19
Munich 13
Seoul 11
Southend 11
Moscow 10
Jacksonville 9
Ann Arbor 7
Lappeenranta 6
New York 6
Ancona 5
Bonndorf 5
Brussels 5
Hong Kong 5
Rome 5
Fairfield 4
Milan 4
Peschiera del Garda 4
Washington 4
Woodbridge 4
Dallas 3
Dongguan 3
Hangzhou 3
Levallois-perret 3
London 3
Neumünster 3
Norwalk 3
Santa Clara 3
Tappahannock 3
Treviso 3
Amsterdam 2
Cambridge 2
Chiuppano 2
Dong Ket 2
Frankfurt am Main 2
Fuzhou 2
Guangzhou 2
Haikou 2
Hebei 2
Krakow 2
Madrid 2
Redwood City 2
San Giovanni Lupatoto 2
Shanghai 2
Shenyang 2
Taiyuan 2
Taizhou 2
Tianjin 2
Toronto 2
Trevenzuolo 2
Turin 2
Vienna 2
Xi'an 2
Ascoli Piceno 1
Auckland 1
Bentivoglio 1
Brescia 1
Brisbane 1
Bucharest 1
Buffalo 1
Cairo 1
Canberra 1
Cassano delle Murge 1
Chicago 1
Clonee 1
Dhaka 1
Dubai 1
Edinburgh 1
Fremont 1
Grafing 1
Gunzenhausen 1
Ho Chi Minh City 1
Jakarta 1
Jiaxing 1
Jinan 1
Kemerovo 1
Las Vegas 1
Laurel 1
Los Angeles 1
Lviv 1
Manila 1
Marino 1
Melbourne 1
Monte Carasso 1
Montignoso 1
Montréal 1
Nanjing 1
Nanning 1
Totale 1.061
Nome #
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 74
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 72
Bile Acids Quantification by Liquid Chromatography-Tandem Mass Spectrometry: Method Validation, Reference Range, and Interference Study 66
Thrombin Generation in Patients with Coronavirus Disease 2019 66
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 66
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 64
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 62
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 61
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 60
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 60
Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay 57
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 56
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 54
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 53
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 48
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 47
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 45
Impact of water temperature on reconstitution of quality controls for routine hemostasis testing 43
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 40
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 38
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 36
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 36
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 33
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 30
Machine learning model comparison in the screening of cholangiocarcinoma using plasma bile acids profiles 30
Monoclonal gammopathy in SARS-CoV-2 infection 29
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 29
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 28
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 27
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 27
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 27
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 25
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 24
Cellular immunity against SARS-CoV-2 depends on the serological status 23
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 21
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 21
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 20
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 19
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 19
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 18
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 18
Impact of the COVID-19 pandemic on the volume of laboratory testing 18
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 18
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 17
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 16
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 16
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 12
Totale 1.769
Categoria #
all - tutte 10.423
article - articoli 10.263
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 160
Totale 20.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 1 1 0 1 1
2020/202181 11 1 1 4 9 5 10 2 3 3 5 27
2021/2022228 31 44 7 9 12 7 5 7 17 7 27 55
2022/2023659 37 55 58 120 37 138 23 59 67 9 30 26
2023/2024408 20 30 19 46 61 50 44 64 3 22 39 10
2024/2025389 59 72 41 165 52 0 0 0 0 0 0 0
Totale 1.769